Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Kearney AY"'
Autor:
Pazina T; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.; FSBSI 'Institute of Experimental Medicine,' St. Petersburg, Russia., James AM; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Colby KB; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Yang Y; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Gale A; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Jhatakia A; Bristol-Myers Squibb, Princeton, New Jersey., Kearney AY; Bristol-Myers Squibb, Princeton, New Jersey., Graziano RF; Bristol-Myers Squibb, Princeton, New Jersey., Bezman NA; Bristol-Myers Squibb, Princeton, New Jersey., Robbins MD; Bristol-Myers Squibb, Princeton, New Jersey., Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. kerry.campbell@fccc.edu adam.cohen@uphs.upenn.edu., Campbell KS; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania. kerry.campbell@fccc.edu adam.cohen@uphs.upenn.edu.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Oct; Vol. 7 (10), pp. 1633-1646. Date of Electronic Publication: 2019 Aug 20.
Autor:
Miao, Sai-Nan1 (AUTHOR), Chai, Meng-Qi1 (AUTHOR), Liu, Xiang-Yu1 (AUTHOR), Wei, Cheng-Yu1 (AUTHOR), Zhang, Cun-Cun1 (AUTHOR), Sun, Ning-Ning1 (AUTHOR), Fei, Qing-Ze1 (AUTHOR), Peng, Lin-Lin1 (AUTHOR), Qiu, Huan1 (AUTHOR) huanqiu@ahmu.edu.cn
Publikováno v:
BMC Cancer. 4/15/2024, Vol. 24 Issue 1, p1-16. 16p.
Autor:
Bezman NA; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Jhatakia A; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Kearney AY; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Brender T; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Maurer M; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Henning K; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Jenkins MR; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Rogers AJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Neeson PJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Korman AJ; Biologics Discovery California, Bristol-Myers Squibb, Redwood City, CA., Robbins MD; Medical Oncology, Bristol-Myers Squibb, Princeton, NJ; and., Graziano RF; Discovery Research, Bristol-Myers Squibb, Lawrenceville, NJ.
Publikováno v:
Blood advances [Blood Adv] 2017 May 08; Vol. 1 (12), pp. 753-765. Date of Electronic Publication: 2017 May 08 (Print Publication: 2017).
Autor:
Bilen MA; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Zurita AJ; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Ilias-Khan NA; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Chen HC; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Wang X; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Kearney AY; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Hodges S; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Jonasch E; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Huang S; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Khakoo AY; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA., Tannir NM; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Department of Cardiology, and Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA; Amgen, Inc., San Francisco, California, USA ntannir@mdanderson.org.
Publikováno v:
The oncologist [Oncologist] 2015 Oct; Vol. 20 (10), pp. 1140-8. Date of Electronic Publication: 2015 Aug 25.
Autor:
Kearney AY; Division of Oncology, Departments of Medicine and Pathology, Molecular Imaging Program, Stanford University, Stanford, CA 94305, USA.; Current Address: Genitourinary Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA., Anchang B; Department of Radiology, Stanford University, Stanford, CA 94305, USA., Plevritis S; Department of Radiology, Stanford University, Stanford, CA 94305, USA., Felsher DW; Division of Oncology, Departments of Medicine and Pathology, Molecular Imaging Program, Stanford University, Stanford, CA 94305, USA.
Publikováno v:
Aging [Aging (Albany NY)] 2015 Sep; Vol. 7 (9), pp. 613-5.
Autor:
Kearney AY; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Fan YH; Department of Thoracic & Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Giri U; Department of Thoracic & Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Saigal B; Department of Thoracic & Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Gandhi V; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Heymach JV; Department of Thoracic & Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Zurita AJ; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Aug 27; Vol. 10 (8), pp. e0135962. Date of Electronic Publication: 2015 Aug 27 (Print Publication: 2015).
Autor:
Liu, Zhaoyun1 (AUTHOR), Xu, Xintong1 (AUTHOR), Liu, Hui1 (AUTHOR), Zhao, Xianghong1 (AUTHOR), Yang, Chun1 (AUTHOR), Fu, Rong1 (AUTHOR) furong8369@tmu.edu.cn
Publikováno v:
Experimental Hematology & Oncology. 11/28/2023, Vol. 12 Issue 1, p1-20. 20p.
Autor:
Wu, Jianhua, Zhou, Zhiyuan, Huang, Yuanwen, Deng, Xinyue, Zheng, Siting, He, Shangwen, Huang, Genjie, Hu, Binghui, Shi, Min, Liao, Wangjun, Huang, Na
Publikováno v:
MedComm; Oct2024, Vol. 5 Issue 10, p1-33, 33p
Autor:
Pereira JL; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal., Arede L; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Ferreira F; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Master´s Program in Bioengineering, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, and Faculty of Engineering, University of Porto, Porto, Portugal., Matos A; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal.; ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.; Genetics Laboratory, Faculty of Medicine, University of Lisbon, Lisboa, Portugal.; Ecogenetics and Human Health, Environmental Health Institute, Faculty of Medicine, University of Lisbon, Lisboa, Portugal., Pereira D; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Department of Hematology and Bone Marrow Transplantation, IPO Porto, Porto, Portugal., Santos RF; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.; ESS-IPP, School of Health, Polytechnic of Porto, Porto, Portugal., Carmo AM; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal., Oliveira MJ; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal.; INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal., Machado JC; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal., Duarte D; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Faculty of Medicine, University of Porto, Porto, Portugal.; Department of Hematology and Bone Marrow Transplantation, IPO Porto, Porto, Portugal., Dos Santos NR; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. nunos@i3s.up.pt.; IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal. nunos@i3s.up.pt.
Publikováno v:
Leukemia [Leukemia] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Markmann, Caroline1,2 (AUTHOR), Bhoj, Vijay G.1,2 (AUTHOR) vbhoj@pennmedicine.upenn.edu
Publikováno v:
Immunological Reviews. Sep2021, Vol. 303 Issue 1, p154-167. 14p.